The 2002 Canadian bone densitometry recommendations: take-home messages.

Case Mrs. B, a 59-year-old woman, asks her family physician about her risk of osteoporosis and fractures. She experienced a radial fracture from a fall earlier this year. She is a nonsmoker and does not drink alcohol regularly. There is no family history of fractures. Her body mass index is 25 kg/

[1]  N. Watts,et al.  Standards and guidelines for performing central dual X-ray densitometry from the Canadian Panel of International Society for Clinical Densitometry. , 2002, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[2]  Jacques P. Brown,et al.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  O. Johnell,et al.  An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women , 2001, Osteoporosis International.

[4]  P. Phillips,et al.  Reproducibility of DXA: Potential Impact on Serial Measurements and Misclassification of Osteoporosis , 2001, Osteoporosis International.

[5]  E. Orwoll.  Assessing Bone Density in Men , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  D. Kiel,et al.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. , 2000, The American journal of medicine.

[7]  Harry K. Genant,et al.  Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial , 2000 .

[8]  C C Glüer,et al.  An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. , 2000, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

[9]  J. Kanis,et al.  An Update on the Diagnosis and Assessment of Osteoporosis with Densitometry , 2000, Osteoporosis International.

[10]  A. Hofman,et al.  Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Executive summary. , 1998, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

[12]  H. Genant,et al.  Low-Dose Esterified Estrogen Therapy: Effects on Bone, Plasma Estradiol Concentrations, Endometrium, and Lipid Levels , 1997 .

[13]  H. Genant,et al.  Diagnosis and Management of Osteoporosis: Guidelines for the Utilization of Bone Densitometry , 1997, Calcified Tissue International.

[14]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[15]  O Johnell,et al.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. , 1996, BMJ.

[16]  G. Breart,et al.  Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study , 1996, The Lancet.

[17]  L. Melton,et al.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. , 1996, Bone.

[18]  J Dequeker,et al.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.

[19]  P. Ross,et al.  Vertebral dimension measurements improve prediction of vertebral fracture incidence. , 1995, Bone.

[20]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[21]  P. Williams-Russo,et al.  Clinical reproducibility of dual energy X‐ray absorptiometry , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  H. Wahner,et al.  Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  Claus Christiansen,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. , 1994, World Health Organization technical report series.

[24]  W. O'Fallon,et al.  Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  C. Cooper,et al.  Population-based study of survival after osteoporotic fractures. , 1993, American journal of epidemiology.

[26]  Claus Christiansen,et al.  Diagnosis of Osteoporosis , 1992, Southern medical journal.

[27]  S. Cummings,et al.  92213370 Appendicular bone mineral and a woman's lifetime risk of hip fracture , 1993 .

[28]  R. Epstein,et al.  Pre-existing fractures and bone mass predict vertebral fracture incidence in women. , 1991, Annals of internal medicine.

[29]  J. Shapiro.  Radiation protection: A guide for scientists and physicians , 1981 .